October 5, 2024

Fertility Services Market Size to Touch US$ 25,720.9 million by 2030

The global fertility services market size is expected to be worth around US$ 25,720.9 million by 2030, according to a new report by Vision Research Reports.

The global fertility services market size was valued at US$ 20,400.61 million in 2020 and is anticipated to grow at a CAGR of 17.8% during forecast period 2021 to 2030.

Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@ https://www.visionresearchreports.com/report/sample/38657

Fertility Services Market (By End-use: Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes; By Service: Fresh Non-donor, Frozen Non-donor, Egg & Embryo Banking, Fresh Donor, Frozen Donor; By Procedure: IVF with ICSI, IUI, IVF without ICSI, Surrogacy, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Treatments or procedures that aid in conception and the treatment of genetic and fertility abnormalities are referred to as reproductive services. Single parents, infertile couples, and members of the Lesbian, Gay, Bisexual, and Transgender (LGBT) community can use Assisted Reproductive Technology (ART) procedures and medications to start a family.

Growth Factors

Fertility services are treatments or procedures used to cure genetic and fertility issues and help with conception. These services include Assisted Reproductive Technology (ART) methods and drugs that help single parents, infertile couples, and the Lesbian, Gay, Bisexual, and Transgender (LGBT) community in planning a family.

Increase in the rate of infertility has occurred majorly due to factors such as increase in the consumption of alcohol and drugs, increased stress level, frequent smoking, obesity, and environmental factors. As per a study by the American Society for Reproductive medicines, in approximately 42% of infertile couples, the male partner is responsible for infertility and among them, approximately 86%-92% are treated with drugs or surgery. This is anticipated to drive the fertility services market growth.

Key Players

  • APOLLO HOSPITALS ENTERPRISE LTD.
  • CARE FERTILITY GROUP LTD.
  • CAROLINAS FERTILITY INSTITUTE
  • CITY FERTILITY
  • FERTILITY ASSOCIATES LIMITED
  • GENEA LIMITED
  • MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK)
  • MONASH IVF GROUP LIMITED
  • PROGYNY INC.
  • VIRTUS HEALTH

Market Segmentation

  • By End User
    • Fertility Clinics
    • Hospitals
    • Surgical Centers
    • Clinical Research Institutes
  • By Service
    • Fresh Non-donor
    • Frozen Non-donor
    • Egg & Embryo Banking
    • Fresh Donor
    • Frozen Donor
  • By Procedure
    • IVF with ICSI
    • IUI
    • IVF without ICSI
    • Surrogacy
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • India
      • China
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Latin America
      • Middle East
      • Africa

Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38657 or call: +1 9197 992 333

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Fertility Services Market, By Services

7.1.  Fertility Services Market, by Services, 2021-2030

7.1.1.    Fertility Clinics

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Hospitals

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Surgical Centers

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Clinical Research Institutes

7.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Fertility Services Market, By Services

8.1.  Fertility Services Market, by Services, 2021-2030

8.1.1.    Fresh Non-donor

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Frozen Non-donor

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Egg & Embryo Banking

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Fresh Donor

8.1.4.1.        Market Revenue and Forecast (2017-2030)

8.1.5.    Frozen Donor

8.1.5.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Fertility Services Market, By Procedure

9.1.  Fertility Services Market, by Procedure, 2021-2030

9.1.1.    IVF with ICSI

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    IUI

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    IVF without ICSI

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Surrogacy

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Fertility Services Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Services (2017-2030)

10.1.2.  Market Revenue and Forecast, by Services (2017-2030)

10.1.3.  Market Revenue and Forecast, by Procedure (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Services (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Services (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Services (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Services (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Services (2017-2030)

10.2.2.  Market Revenue and Forecast, by Services (2017-2030)

10.2.3.  Market Revenue and Forecast, by Procedure (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Services (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Services (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Services (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Services (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Services (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Services (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Services (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Services (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Services (2017-2030)

10.3.2.  Market Revenue and Forecast, by Services (2017-2030)

10.3.3.  Market Revenue and Forecast, by Procedure (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Services (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Services (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Services (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Services (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Services (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Services (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Services (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Services (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Services (2017-2030)

10.4.2.  Market Revenue and Forecast, by Services (2017-2030)

10.4.3.  Market Revenue and Forecast, by Procedure (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Services (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Services (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Services (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Services (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Services (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Services (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Services (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Services (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Services (2017-2030)

10.5.2.  Market Revenue and Forecast, by Services (2017-2030)

10.5.3.  Market Revenue and Forecast, by Procedure (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Services (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Services (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Services (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Services (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by Procedure (2017-2030)

Chapter 11.  Company Profiles

11.1.              APOLLO HOSPITALS ENTERPRISE LTD.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              CARE FERTILITY GROUP LTD.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              CAROLINAS FERTILITY INSTITUTE

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              CITY FERTILITY

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              FERTILITY ASSOCIATES LIMITED

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              GENEA LIMITED

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK)

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              MONASH IVF GROUP LIMITED

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              PROGYNY INC.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           VIRTUS HEALTH

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38657 or call: +1 9197 992 333

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →